TY - JOUR
T1 - Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer
AU - Tong, Kevin
AU - Pellón-Cárdenas, Oscar
AU - Sirihorachai, Veerin R.
AU - Warder, Bailey N.
AU - Kothari, Om A.
AU - Perekatt, Ansu O.
AU - Fokas, Emily E.
AU - Fullem, Robert L.
AU - Zhou, Anbo
AU - Thackray, Joshua K.
AU - Tran, Hiep
AU - Zhang, Lanjing
AU - Xing, Jinchuan
AU - Verzi, Michael P.
N1 - Publisher Copyright:
© 2017 The Author(s)
PY - 2017/12/26
Y1 - 2017/12/26
N2 - Oncogenic mutations in BRAF are believed to initiate serrated colorectal cancers; however, the mechanisms of BRAF-driven colon cancer are unclear. We find that oncogenic BRAF paradoxically suppresses stem cell renewal and instead promotes differentiation. Correspondingly, tumor formation is inefficient in BRAF-driven mouse models of colon cancer. By reducing levels of differentiation via genetic manipulation of either of two distinct differentiation-promoting factors (Smad4 or Cdx2), stem cell activity is restored in BRAF V600E intestines, and the oncogenic capacity of BRAF V600E is amplified. In human patients, we observe that reduced levels of differentiation in normal tissue is associated with increased susceptibility to serrated colon tumors. Together, these findings help resolve the conditions necessary for BRAF-driven colon cancer initiation. Additionally, our results predict that genetic and/or environmental factors that reduce tissue differentiation will increase susceptibility to serrated colon cancer. These findings offer an opportunity to identify susceptible individuals by assessing their tissue-differentiation status. Despite high frequency in serrated colon tumors, BRAF V600E inefficiently drives tumorigenesis in mouse models, and paradoxically, BRAF V600E triggers stem cell loss. BRAF-driven tumorigenesis increases in genetic models that reduce differentiation and restore stem cell activity. These findings provide insights into the mechanisms of BRAF V600E -driven colon cancer initiation.
AB - Oncogenic mutations in BRAF are believed to initiate serrated colorectal cancers; however, the mechanisms of BRAF-driven colon cancer are unclear. We find that oncogenic BRAF paradoxically suppresses stem cell renewal and instead promotes differentiation. Correspondingly, tumor formation is inefficient in BRAF-driven mouse models of colon cancer. By reducing levels of differentiation via genetic manipulation of either of two distinct differentiation-promoting factors (Smad4 or Cdx2), stem cell activity is restored in BRAF V600E intestines, and the oncogenic capacity of BRAF V600E is amplified. In human patients, we observe that reduced levels of differentiation in normal tissue is associated with increased susceptibility to serrated colon tumors. Together, these findings help resolve the conditions necessary for BRAF-driven colon cancer initiation. Additionally, our results predict that genetic and/or environmental factors that reduce tissue differentiation will increase susceptibility to serrated colon cancer. These findings offer an opportunity to identify susceptible individuals by assessing their tissue-differentiation status. Despite high frequency in serrated colon tumors, BRAF V600E inefficiently drives tumorigenesis in mouse models, and paradoxically, BRAF V600E triggers stem cell loss. BRAF-driven tumorigenesis increases in genetic models that reduce differentiation and restore stem cell activity. These findings provide insights into the mechanisms of BRAF V600E -driven colon cancer initiation.
KW - BRAF
KW - Cdx2
KW - Smad4
KW - intestinal homeostasis
KW - serrated colorectal cancer
UR - http://www.scopus.com/inward/record.url?scp=85039964307&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85039964307&partnerID=8YFLogxK
U2 - 10.1016/j.celrep.2017.11.104
DO - 10.1016/j.celrep.2017.11.104
M3 - Article
C2 - 29281831
AN - SCOPUS:85039964307
VL - 21
SP - 3833
EP - 3845
JO - Cell Reports
JF - Cell Reports
IS - 13
ER -